Neurologic clinical trial - RA101495-02.302 (RAISE‧XT)

Status:

Start-Up

A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects with Generalized Myasthenia Gravis

Drug

Zilucoplan

Phase

Phase 3

Condition

Generalized Myasthenia Gravis Myasthenia Gravis

Keywords

Ra Pharmaceuticals, Inc.